VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Freedland on the Association Between Carbohydrates and Prostate Cancer Risk

Stephen J. Freedland, MD
Published: Wednesday, Aug 06, 2014

Stephen J. Freedland, MD, associate professor, Duke University, discusses an analysis presented at the 2014 AUA Annual Meeting that looked at carbohydrate intake, glycemic index, and prostate cancer risk.

Freedland says this case-controlled study analyzed men undergoing biopsy and had them fill out a questionnaire about their food intake. The trial also looked at men who were screened for prostate cancer but were not recommended to undergo biopsy. Only the men that underwent biopsy and found to have prostate cancer were included in the study.

The study found that men who consumed more carbohydrates with a low glycemic index were at a lower risk of prostate cancer, Freedland says. The study also found that high fiber intake helped protect patients against prostate cancer.
 
Stephen J. Freedland, MD, associate professor, Duke University, discusses an analysis presented at the 2014 AUA Annual Meeting that looked at carbohydrate intake, glycemic index, and prostate cancer risk.

Freedland says this case-controlled study analyzed men undergoing biopsy and had them fill out a questionnaire about their food intake. The trial also looked at men who were screened for prostate cancer but were not recommended to undergo biopsy. Only the men that underwent biopsy and found to have prostate cancer were included in the study.

The study found that men who consumed more carbohydrates with a low glycemic index were at a lower risk of prostate cancer, Freedland says. The study also found that high fiber intake helped protect patients against prostate cancer.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x